7. GRI content index

PolyPeptide has produced its report for the period 1 January 2024 to 31 December 2024 with reference to the GRI Standards.

GRI 1 used

GRI 1: Foundation 2021

Applicable GRI Sector Standard(s)

None

General Disclosures

GRI Standard

Disclosure

Reference/ information

Article links

Omission

 

 

 

 

 

 

 

The organization and its reporting practices

GRI 2: General Disclosures 2021

2-1

Organizational details

PolyPeptide in brief, page 8

https://report.polypeptide.com/ar/24/en/?p=2322

 

Strategy, page 10

https://report.polypeptide.com/ar/24/en/?p=2344

 

Group structure and shareholders, page 82

https://report.polypeptide.com/ar/24/en/?p=2217

 

Notes to the consolidated financial statements, page 174

https://report.polypeptide.com/ar/24/en/?p=2198

 

2-2

Entities included in the organization’s sustainability reporting

Sustainability approach, page 19

https://report.polypeptide.com/ar/24/en/?p=2169

 

Group structure and shareholders, page 82

https://report.polypeptide.com/ar/24/en/?p=2217

 

2-3

Reporting period, frequency and contact point

Introduction, page 18

https://report.polypeptide.com/ar/24/en/?p=2214

 

Imprint, page 241

https://report.polypeptide.com/ar/24/en/?p=2162

 

2-4

Restatements of information

None

 

 

2-5

External assurance

Independent practitioner's limited assurance report on selected non-financial information 2024, page 76

https://report.polypeptide.com/ar/24/en/?p=2374

 

 

 

 

 

 

 

 

Activities and workers

GRI 2: General Disclosures 2021

2-6

Activities, value chain and other business relationships

Strategy, page 10

https://report.polypeptide.com/ar/24/en/?p=2344

 

2-7 a., c., d., e.

Employees

People, page 34-37

https://report.polypeptide.com/ar/24/en/?p=2297/#people

 

 

 

 

 

 

 

 

Governance

GRI 2: General Disclosures 2021

2-9

Governance structure and composition

Board of Directors, page 90

https://report.polypeptide.com/ar/24/en/?p=2357

 

2-10

Nomination and selection of the highest governance body

Election and term of office, page 99

https://report.polypeptide.com/ar/24/en/?p=2357/#bodelectionandtermofoffice

 

Remuneration and Nomination Committee, page 137

https://report.polypeptide.com/ar/24/en/?p=2366/#roleandactivitiesoftheremunerationandnominationcommittee

 

2-11

Chair of the highest governance body

Members of the Board of Directors, page 91

https://report.polypeptide.com/ar/24/en/?p=2357/#membersofthebod

 

Internal organizational structure, page 100

https://report.polypeptide.com/ar/24/en/?p=2357/#internalorganizationalstructure

 

2-12

Role of the highest governance body in overseeing the management of impacts

Responsibilities and organization, page 19

https://report.polypeptide.com/ar/24/en/?p=2169

 

2-13

Delegation of responsibility for managing impacts

Responsibilities and organization, page 19

https://report.polypeptide.com/ar/24/en/?p=2169

 

2-14

Role of the highest governance body in sustainability reporting

Responsibilities and organization, page 19

https://report.polypeptide.com/ar/24/en/?p=2169

 

2-15

Conflicts of interest

Internal organizational structure, page 100

https://report.polypeptide.com/ar/24/en/?p=2357/#internalorganizationalstructure

 

 

 

 

 

 

 

 

 

2-16

Communication of critical concerns

Organizational Regulations

https://www.polypeptide.com/company/downloads/

 

Business ethics and compliance, page 37-39

https://report.polypeptide.com/ar/24/en/?p=2297/#businessethicsandcompliance

 

Information and control instruments vis-à-vis the Executive Committee, page 111

https://report.polypeptide.com/ar/24/en/?p=2357/#informationandcontrolinstrumentsvisavistheexecutivecommittee

 

2-17

Collective knowledge of the highest governance body

Board of Directors, page 90

https://report.polypeptide.com/ar/24/en/?p=2357

 

2-18

Evaluation of the performance of the highest governance body

Remuneration Report, page 134

https://report.polypeptide.com/ar/24/en/?p=2366

 

2-19

Remuneration policies

Articles of Association

https://www.polypeptide.com/investors/results-center/results-2024/

 

2-20

Process to determine remuneration

Role and activities of the Board of Directors and shareholders, page 135-136

https://report.polypeptide.com/ar/24/en/?p=2357/#roleandactivitiesoftheboardofdirectorsandshareholders

 

Role and activities of the Remuneration and Nomination Committee, page 137-138

https://report.polypeptide.com/ar/24/en/?p=2357/#roleandactivitiesoftheremunerationandnominationcommittee

 

 

 

 

 

 

 

 

Strategy, policies and practices

GRI 2: General Disclosures 2021

2-22

Statement on sustainable development strategy

Editorial, page 4

https://report.polypeptide.com/ar/24/en/?p=2333

 

2-23

Policy commitments

Business ethics and compliance, page 38

https://report.polypeptide.com/ar/24/en/?p=2297/#businessethicsandcompliance

 

2-24

Embedding policy commitments

Business ethics and compliance, page 38-39

https://report.polypeptide.com/ar/24/en/?p=2297/#businessethicsandcompliance

 

2-25

Processes to remediate negative impacts

Compliance controls, page 113

https://report.polypeptide.com/ar/24/en/?p=2357/#compliancecontrols

 

2-26

Mechanisms for seeking advice and raising concerns

Compliance controls, page 113

https://report.polypeptide.com/ar/24/en/?p=2357/#compliancecontrols

 

2-27

Compliance with laws and regulations

Business ethics and compliance, page 38

https://report.polypeptide.com/ar/24/en/?p=2297/#businessethicsandcomplianceachievements2024

 

2-28

Membership associations

Stakeholder engagement, page 21

https://report.polypeptide.com/ar/24/en/?p=2169/#stakeholderengagement

 

 

 

 

 

 

 

 

Stakeholder engagement

GRI 2: General Disclosures 2021

2-29

Approach to stakeholder engagement

Stakeholder engagement, page 21

https://report.polypeptide.com/ar/24/en/?p=2169/#stakeholderengagement

 

2-30

Collective bargaining agreements

People, page 35

https://report.polypeptide.com/ar/24/en/?p=2297/#peopleachievements2024

 

 

 

 

 

 

 

 

Material topics

GRI Standard

Disclosure

Reference/ information

Article links

Omission

 

 

 

 

 

 

 

 

GRI 3: Material Topics 2021

3-1

Process to determine material topics

Identification of material topics, page 23

https://report.polypeptide.com/ar/24/en/?p=2174/#identificationofmaterialtopics

 

3-2

List of material topics

Materiality matrix, page 24

https://report.polypeptide.com/ar/24/en/?p=2174/#materialitymatrix

 

 

 

 

 

 

 

 

Product responsibility

GRI 3: Material Topics 2021

3-3

Management of material topics

Product responsibility, page 27

https://report.polypeptide.com/ar/24/en/?p=2297/#productresponsibility

 

Own indicator

Revenue structure

Product responsibility, page 28

https://report.polypeptide.com/ar/24/en/?p=2297/#peopleresponsibilityachievements2024

 

Own indicator

Project pipeline

Product responsibility, page 28

https://report.polypeptide.com/ar/24/en/?p=2297/#peopleresponsibilityachievements2024

 

Own indicator

Generics portfolio

Product responsibility, page 28

https://report.polypeptide.com/ar/24/en/?p=2297/#peopleresponsibilityachievements2024

 

Own indicator

Delivery performance

Product responsibility, page 29

https://report.polypeptide.com/ar/24/en/?p=2297/#peopleresponsibilityachievements2024

 

 

 

 

 

 

 

 

Green chemistry

GRI 3: Material Topics 2021

3-3

Management of material topics

Green chemistry, page 29

https://report.polypeptide.com/ar/24/en/?p=2297/#greenchemistry

 

GRI 303: Water and Effluents 2018

303-5, a.

Water consumption

Green chemistry, page 31

https://report.polypeptide.com/ar/24/en/?p=2297/#greenchemistryachievements2024

 

Own indicator

Solvent consumption

Green chemistry, page 31

https://report.polypeptide.com/ar/24/en/?p=2297/#greenchemistryachievements2024

 

Own indicator

Green solvent projects

Green chemistry, page 31

https://report.polypeptide.com/ar/24/en/?p=2297/#greenchemistryachievements2024

 

Own indicator

Percolation deployment

Green chemistry, page 31

https://report.polypeptide.com/ar/24/en/?p=2297/#greenchemistryachievements2024

 

 

 

 

 

 

 

 

Climate change mitigation

GRI 3: Material Topics 2021

3-3

Management of material topics

Climate Report, page 40

https://report.polypeptide.com/ar/24/en/?p=2519

 

GRI 302: Energy 2016

302-1, c.i.

Energy consumption within the organization

Climate Report, page 52-58

https://report.polypeptide.com/ar/24/en/?p=2519/#Metricsandtargets

 

GRI 305: Emissions 2016

305-1

Direct (Scope 1) GHG emissions

Climate Report, page 52

https://report.polypeptide.com/ar/24/en/?p=2519/#Metricsandtargets

 

305-2

Energy indirect (Scope 2) GHG emissions

Climate Report, page 52

https://report.polypeptide.com/ar/24/en/?p=2519/#Metricsandtargets

 

305-3

Other indirect (Scope 3) emissions

Climate Report, page 52

https://report.polypeptide.com/ar/24/en/?p=2519/#Metricsandtargets

 

Own indicator

Renewable electricity

Climate Report, page 56, 59

https://report.polypeptide.com/ar/24/en/?p=2519/#Metricsandtargets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Supply chain engagement

GRI 3: Material Topics 2021

3-3

Management of material topics

Supply chain engagement, page 32

https://report.polypeptide.com/ar/24/en/?p=2297/#supplychainengagement

 

Own indicator

Supplier assessment

Supply chain engagement, page 33

https://report.polypeptide.com/ar/24/en/?p=2297/#supplychainengagementachievements2024

 

 

 

 

 

 

 

 

People

GRI 3: Material Topics 2021

3-3

Management of material topics

People, page 34

https://report.polypeptide.com/ar/24/en/?p=2297/#people

 

GRI 403: Occupational health and safety 2018

403-9, a. ii.

Work-related injuries

People, page 35

https://report.polypeptide.com/ar/24/en/?p=2297/#peopleachievements2024

 

Own indicator

Employee engagement

People, page 35

https://report.polypeptide.com/ar/24/en/?p=2297/#peopleachievements2024

 

 

 

 

 

 

 

 

Business ethics and compliance

GRI 3: Material Topics 2021

3-3

Management of material topics

Business ethics and compliance, page 37

https://report.polypeptide.com/ar/24/en/?p=2297/#businessethicsandcompliance

 

GRI 205: Anti-corruption 2016

205-3

Confirmed incidents of corruption and actions taken

Business ethics and compliance, page 39

https://report.polypeptide.com/ar/24/en/?p=2297/#businessethicsandcomplianceachievements2024

 

GRI 206: Anti-competitive behavior 2016

206-1

Legal actions for anti-competitive behavior, anti-trust, and monopoly practices

Business ethics and compliance, page 39

https://report.polypeptide.com/ar/24/en/?p=2297/#businessethicsandcomplianceachievements2024

 

Own indicator

IT security training

Business ethics and compliance, page 39

https://report.polypeptide.com/ar/24/en/?p=2297/#businessethicsandcomplianceachievements2024

 

Own indicator

Whistleblower training

Business ethics and compliance, page 39

https://report.polypeptide.com/ar/24/en/?p=2297/#businessethicsandcomplianceachievements2024